ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Mingwei Dong
Matched on ORCID iD 0000-0002-0662-3925; OpenAlex author ID A5043906289. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 5
- Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort. Co-author DOI 10.1002/cam4.72083↗
- ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer. First author DOI 10.1053/j.gastro.2025.09.032↗
- The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression through the SRC/YAP signaling pathway. Co-author DOI 10.1016/j.tranon.2025.102346↗
- NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy. Co-author DOI 10.1038/s41419-024-06984-0↗
- Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma: Hypoxi… Co-author DOI 10.1016/j.tranon.2023.101692↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Si Shi · 4 shared papers, 2023–2026 · strength 0.83
- Paper ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer. DOI 10.1053/j.gastro.2025.09.032↗
- Paper The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression … DOI 10.1016/j.tranon.2025.102346↗
- Paper NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced auto… DOI 10.1038/s41419-024-06984-0↗
- Jie Hua · 3 shared papers, 2023–2026 · strength 0.67
- Paper Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort. DOI 10.1002/cam4.72083↗
- Paper ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer. DOI 10.1053/j.gastro.2025.09.032↗
- Paper Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable progno… DOI 10.1016/j.tranon.2023.101692↗
- Qingcai Meng · 3 shared papers, 2023–2026 · strength 0.62
- Paper ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer. DOI 10.1053/j.gastro.2025.09.032↗
- Paper The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression … DOI 10.1016/j.tranon.2025.102346↗
- Paper Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable progno… DOI 10.1016/j.tranon.2023.101692↗
- Jin Xu · 3 shared papers, 2023–2026 · strength 0.62
- Paper ENPP1-Regulated Extracellular Purine Metabolism Drives Pancreatitis-Mediated Pancreatic Cancer. DOI 10.1053/j.gastro.2025.09.032↗
- Paper The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression … DOI 10.1016/j.tranon.2025.102346↗
- Paper Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable progno… DOI 10.1016/j.tranon.2023.101692↗
- Miaoyan Wei · 2 shared papers, 2025–2026 · strength 0.49
- Paper Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort. DOI 10.1002/cam4.72083↗
- Paper The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression … DOI 10.1016/j.tranon.2025.102346↗
- Rong Tang · 2 shared papers, 2023–2026 · strength 0.44
- Paper Genomic Alterations and Their Clinical Implications in Pancreatic Ductal Adenocarcinoma in a Large-Scale Chinese Cohort. DOI 10.1002/cam4.72083↗
- Paper Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable progno… DOI 10.1016/j.tranon.2023.101692↗
- Mingming Xiao · 2 shared papers, 2024–2026 · strength 0.44
- Xianjun Yu · 2 shared papers, 2023–2025 · strength 0.39
- Paper The pancreatitis-cancer transformation-related factor, human rhomboid family-1, promotes pancreatic cancer progression … DOI 10.1016/j.tranon.2025.102346↗
- Paper Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable progno… DOI 10.1016/j.tranon.2023.101692↗
- Ying Liu · 1 shared paper, 2026 · strength 0.27
- Qiong Du · 1 shared paper, 2026 · strength 0.27
- Xu Jk · 1 shared paper, 2026 · strength 0.27
- Daohai Qian · 1 shared paper, 2026 · strength 0.23
- Zhenshun Song · 1 shared paper, 2026 · strength 0.23
- Di Wu · 1 shared paper, 2026 · strength 0.23
- Zhilong Ma · 1 shared paper, 2026 · strength 0.23
- Zhilong Ma · 1 shared paper, 2025 · strength 0.22
- Xuhui Tong · 1 shared paper, 2024 · strength 0.21
- Xiaoqi Mao · 1 shared paper, 2024 · strength 0.21
- Xianjun Yu · 1 shared paper, 2024 · strength 0.21
- Yalan Lei · 1 shared paper, 2024 · strength 0.21
- H. J. Yang · 1 shared paper, 2024 · strength 0.21
- Bo Zhang · 1 shared paper, 2023 · strength 0.17
- Chen Liang · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.